annual cash & cash equivalents:
$2.55B-$434.43M(-14.58%)Summary
- As of today (September 6, 2025), XPEV annual cash & cash equivalents is $2.55 billion, with the most recent change of -$434.43 million (-14.58%) on December 31, 2024.
- During the last 3 years, XPEV annual cash & cash equivalents has risen by +$816.38 million (+47.20%).
- XPEV annual cash & cash equivalents is now -43.05% below its all-time high of $4.47 billion, reached on December 31, 2020.
Performance
XPEV Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$5.64B+$361.48M(+6.85%)Summary
- As of today (September 6, 2025), XPEV quarterly cash & cash equivalents is $5.64 billion, with the most recent change of +$361.48 million (+6.85%) on June 1, 2025.
- Over the past year, XPEV quarterly cash & cash equivalents has increased by +$1.22 billion (+27.52%).
- XPEV quarterly cash & cash equivalents is now -14.92% below its all-time high of $6.63 billion, reached on September 30, 2021.
Performance
XPEV quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XPEV Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.6% | +27.5% |
| 3 y3 years | +47.2% | +15.7% |
| 5 y5 years | +815.0% | +1782.5% |
XPEV Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.6% | +47.2% | -4.6% | +49.0% |
| 5 y | 5-year | -43.0% | +815.0% | -14.9% | +1782.5% |
| alltime | all time | -43.0% | +976.5% | -14.9% | +1926.0% |
XPEV Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $5.64B(+6.9%) |
| Mar 2025 | - | $5.28B(+7.0%) |
| Dec 2024 | $2.55B(-14.6%) | $4.93B(+15.4%) |
| Sep 2024 | - | $4.27B(-3.3%) |
| Jun 2024 | - | $4.42B(-14.0%) |
| Mar 2024 | - | $5.14B(-13.0%) |
| Dec 2023 | $2.98B(+40.8%) | $5.91B(+38.4%) |
| Sep 2023 | - | $4.27B(+5.9%) |
| Jun 2023 | - | $4.03B(+6.5%) |
| Mar 2023 | - | $3.78B(-16.0%) |
| Dec 2022 | $2.12B | $4.51B(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $4.48B(-8.1%) |
| Jun 2022 | - | $4.87B(-13.7%) |
| Mar 2022 | - | $5.64B(-10.8%) |
| Dec 2021 | $1.73B(-61.3%) | $6.33B(-4.5%) |
| Sep 2021 | - | $6.63B(+39.7%) |
| Jun 2021 | - | $4.74B(-11.9%) |
| Mar 2021 | - | $5.38B(-0.4%) |
| Dec 2020 | $4.47B(+1506.7%) | $5.40B(+84.0%) |
| Sep 2020 | - | $2.94B(+880.5%) |
| Jun 2020 | - | $299.47M(+7.6%) |
| Dec 2019 | $278.26M(+17.7%) | $278.26M |
| Dec 2018 | $236.50M | - |
FAQ
- What is XPeng Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for XPeng Inc.?
- What is XPeng Inc. annual cash & cash equivalents year-on-year change?
- What is XPeng Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for XPeng Inc.?
- What is XPeng Inc. quarterly cash & cash equivalents year-on-year change?
What is XPeng Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of XPEV is $2.55B
What is the all time high annual cash & cash equivalents for XPeng Inc.?
XPeng Inc. all-time high annual cash & cash equivalents is $4.47B
What is XPeng Inc. annual cash & cash equivalents year-on-year change?
Over the past year, XPEV annual cash & cash equivalents has changed by -$434.43M (-14.58%)
What is XPeng Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of XPEV is $5.64B
What is the all time high quarterly cash & cash equivalents for XPeng Inc.?
XPeng Inc. all-time high quarterly cash & cash equivalents is $6.63B
What is XPeng Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, XPEV quarterly cash & cash equivalents has changed by +$1.22B (+27.52%)